Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 9, 2008, Pages 1226-1230

  Yokoyama, T ^a   Yamasaki, F ^a   Yamashita, K ^a   Manabe, M ^a   Suwa, K ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Teikyo Junior College   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; BLEEDING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS;

ADULT; ASPIRIN; BLEEDING TIME; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE;

EID: 51749100060     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01766.x     Document Type: Article

References (28)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 : 71 86.
2. Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005 353 : 2373 83.
3. Samama CM, Bastien O, Forestier F, Denninger MH, Isetta C, Juliard JM, Lasne D, Leys D, Mismetti P. French Society of Anesthesiology and Intensive Care. Antiplatelet agents in the perioperative period: expert recommendations of the French society of anesthesiology and intensive care (SFAR) 2001-summary statement. Can J Anaesth 2002 49 : s26 35.
4. Matsuzaki K, Okabe H, Kajihara N, Haraguchi N, Nagano I, Tatewaki H, Matsui K. A prospective study on the timing of discontinuation of aspirin before coronary artery bypass grafting. J Jpn Thorac Surg 1997 45 : 1710 4.
5. Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000 76 : 257 8.
6. Bachman DS. Discontinuing chronic aspirin therapy: another risk factor for stroke? Ann Neurol 2002 51 : 137 8.
7. Marucus AJ. Aspirin and thromboembolism - a possible dilemma. N Engl J Med 1977 297 : 1284 5.
8. Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA Jr. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 1983 308 : 800 5.
9. Hamberg M, Svensson J, Samuelsson B. Thromboxane: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975 72 : 2994 8.
10. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2nd., Lawson JA, Brash AR. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983 71 : 678 88.
11. Moncada S, Higgas EA, Vane JR. Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977 1 : 18 20.
12. Armen PC, Ellman L, Harris WH. Aspirin-induced prolongation of bleeding time and perioperative blood loss. JAMA 1981 245 : 1825 8.
13. Aktas B, Pozgajova M, Bergmeier W, Sunnarborg S, Offermanns S, Lee D, Wagner DD, Nieswandt B. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biochem 2005 280 : 39716 22.
14. Loew D, Vinazzer H. Dose-dependent influence of acetylsalicyclic acid on platelet functions and plasmatic coagulation factors. Haemostasis 1976 5 : 239 49.
15. Roncaglioni MC, Ulrich MM, Muller AD, Soute BA, de Boer-van den Berg MA, Vermeer C. The vitamin K-antagonism of salicylate and warfarin. Thromb Res 1986 42 : 727 36.
16. Satoh K, Ozaki Y, Qi R, Yang L, Asazuma N, Yatomi Y, Kume S. Factors that affect the size of platelet aggregates in epinephrine-induced activation: a study using the particle counting method based upon light scattering. Thromb Res 1996 81 : 515 23.
17. Yokoyama T, Yamashita K, Yamasaki F, Ueta T, Manabe M, Nishiyama T. Aspirin reversal - an incremental administration of aspirin shortens the bleeding time prolonged by low-dose aspirin. Masui 2003 52 : 399 401.
18. Ivy AC, Shapiro PA, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obstet 1935 60 : 781 4.
19. Born GVR. Quantitative investigations into the aggregation of blood platelet. J Physiol 1962 162 : 67 8.
20. O'Breien JR. Platelet aggregation II. Some results from a new method of study. J Clin Pathol 1962 15 : 452 5.
21. Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 1990 15 : 15 20.
22. Kallis P, Tooze JA, Talbot S, Cowans D, Bevan DH, Treasure T. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss - a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994 8 : 404 9.
23. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y, Lancaster L, Emery R, Sharma GVRK, Josa M, Pacold I, Montoya A, Parikh D, Sethi G, Holt J, Kirklin J, Shabetai R, Moores W, Aldridge J, Masud Z, DeMots H, Floten S, Haakenson C, Harker LA. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 1988 77 : 1324 32.
24. Roizen MF. Anesthetic implications of concurrent diseases. In : Millar RD, ed. Anesthesia, 5th edn. New York : Churchill Livingstone, 2000 : 9 88.
25. Komatsu T, Tamai Y, Takami H, Yamagata K, Fukuda S, Munakata A. Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures. J Gastroenterol 2005 40 : 698 707.
26. Peterson P, Hayes TE, Arkin CF, Bovill EG, Fairweather RB, Rock WA Jr., Triplett DA, Brandt JT. The preoperative bleeding time test lacks clinical benefit: college of American pathologists' and American society of clinical pathologists' position article. Arch Surg 1998 133 : 134 9.
27. Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA 2007 297 : 2018 24.
28. Mielke CH Jr. Aspirin prolongation of the template bleeding time: influence of venostasis and direction of incision. Blood 1982 60 : 1139 42.